NASDAQ NMS - GLOBAL MARKET · TXG

-3.50% · -$2.53 · Vol Not reported

Market closed · last close 4:00 PM ET · price as of 16:00:00 ET

10X Genomics Inc

Life Sciences Tools & Services

$69.86

Card

Relationship Map

Follow $TXG

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $TXG by email

Veridion Score

BETAMEDIUM CONF · 6 of 6 factors measured

Fri Oct 16 · last completed session · Markets closed · resumes Mon 9:30 ET · TXG

Methodology

TXG

10X Genomics Inc

Fri Oct 16 · last completed session · Markets closed · resumes Mon 9:30 ET

59/100

Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100

Veridion Score

Middle range · MEDIUM confidence · 6 of 6 factors measured

Sovereign · $25/mo

See why this score moved.

· Factor breakdown with raw signals
· Day-over-day delta + driver
· Factor coverage readout
· Valuation · hype · market flow
· Pro Chart event markers
· Score history + alerts

Start Sovereign · $25/mo →or $250/yr

Cancel anytime · or Reserve · $79/mo or $790/yr

Confidence: MEDIUM · 6 of 6 factors measured · Fri Oct 16 · last completed session · Markets closed · resumes Mon 9:30 ET

Share on X →

AI Analysis

Sovereign

Why is TXG moving today?

Sovereign unlock connects news, insider activity, analyst moves, and available price action.

Catalyst calendar

What can move TXG next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Score

Upcoming

No dated upcoming catalyst is present in the current source window.

Recent

Oct 16
Score
Score moved -12
71/Upper range -> 59/Middle range
Veridion score historySource

About 10X Genomics Inc

LABORATORY ANALYTICAL INSTRUMENTS

Listed since

2019

Employees

Country

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$71.91

Day high

$73.99

Day low

$67.52

Previous close

$72.39

52W high

$97.74

-28.52% from high

52W low

$12.26

67% of range

Market cap

$9.1B

EPS

$-0.5897

Beta

2.10

Shares out

130.3M

Avg volume

3.8M

VWAP

$72.39

Last session

Price history computed in-house

-13.38%

-8.80%

+61.64%

+490.53%

YTD

+328.33%

SMA 50 $70.90 · below

SMA 200 $37.81 · above

52W position 67%

TXG overview

Veridion Score

Registered · 2026-10-16

6 of 6 factors measured

Latest receipt rows

No recent disclosure on file.

13F holders

None on file

Relationship mapTrace receipt-backed holders and filings around TXG.Congress trackerSearch the public STOCK Act disclosure ledger.Thematic map · TechBio & AI Drug Discovery MethodologyReview score inputs, coverage rules, and limitations.

SEC Form 4 ledger

TXG insider activity

10X Genomics Inc

90 days, by filing date. Issuer coverage time not measured. Published Oct 17, 2026, 5:36 PM EDT.

Score

Not evaluated

Pressure

Not evaluated

Open-market Transactions

Not measured

Filings with trades

Not measured

Buys / sells

Not measured

Net value

Not evaluated

Insiders trading

Not measured

Cluster

Not covered: this ticker is outside our Form 4 ingest scope — we have not looked

Net pressure

Not evaluated: no value-bearing Form 4 rows are loaded.

Convergence not evaluated

No value-bearing Form 4 rows are loaded, so cross-source convergence is not evaluated.

Form 4 evidence state

Not covered: this ticker is outside our Form 4 ingest scope — we have not looked.

Source: SEC EDGAR Form 4. Counts open-market purchases (code P) and sales (code S) only; grants, tax withholding, gifts and option exercises are not counted. Rows with missing price or quantity are excluded rather than zero-filled.Methodology

Public disclosures

Congress activity in TXG

Congress tracker Open ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

TXG contract awards, year to date.

Public federal awards linked to this ticker.

$3.0M

Refresh interval: 12hSource: Federal contract awards

Department of Health and Human Services

$559.5K

NIAMS

NIAMS: SUPPLY: 10X GENOMICS ATERA PLATFORM: N/A

Aug 27, 2026

Department of Veterans Affairs

$350.0K

10X GENOMICS TEST KITS

Jun 15, 2026

Department of Health and Human Services

$300.6K

NIMH

NIMH: SUPPLY: DIAGNOSTIC LABORATORY EQUIPMENT: N/A FOR THE HBCC SINGLE-NUCLEUS SEQUEN...

Sep 28, 2026

Department of Health and Human Services

$250.0K

NIA - BIOLOGIC KITS AND SAMPLES - NON-SEVERABLE

Sep 22, 2026

Department of Veterans Affairs

$199.3K

REAGENTS FOR USE ON CHROMIUM SYSTEM FROM 10X GENOMICS, INC

Sep 28, 2026

Lobbying spend

TXG lobbying filings, year to date.

Registered lobbying filings matched to 10X Genomics Inc.

Not disclosed

Refresh interval: 12hSource: LDA disclosure filings

No lobbying filings on file for TXG in this window.

Analyst ratings

Sovereign unlock shows available analyst consensus for TXG.

Related tickers

Cross-references from this score page.

Apprentice · 1 rail

Similar headline score

Nearest public composite scores. Factor similarity requires Sovereign.

Keep reading

Computed from served filings. Monthly/week selections use filing dates; stock overlap uses the last 180 trade-date days. Disclosed ranges are not exact trade values.

Most active this month
Gilbert Ray Cisneros, Jr. →
57 receipt-qualified rows filed this UTC calendar month
Receipt · filed Oct 12, 2026
Newest filing
David J. Taylor →
Receipt · filed Oct 15, 2026
Largest disclosed range this week
Scott H. Peters →
$250,001 - $500,000
Receipt · filed Oct 15, 2026
Latest Pelosi filing
Nancy Pelosi →
Receipt · filed Oct 2, 2026
President’s latest served report
Donald J. Trump →
Receipt · filed Sep 25, 2026
Most members trading
MSFT →
12 distinct congressional filers with purchases or sales in the transaction-date 180-day window
Receipt · filed Oct 12, 2026

Accepted first-party filing records · computed Oct 17, 8:51 PM ET.

Follow $TXG

Why is TXG moving today?

What can move TXG next.

TXG overview

Related filings and maps

TXG insider activity

TXG contract awards, year to date.

TXG lobbying filings, year to date.

Cross-references from this score page.

What can move TXG next.

TXG insider activity

Cross-references from this score page.